Palmisano BT, Zhu L, Stafford JM. Role of Estrogens in the regulation of liver lipid metabolism. Adv Exp Med Biol. 2017;1043:227–56. https://doi.org/10.1007/978-3-319-70178-3_12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lloyd-Jones D, et al. Heart disease and stroke statistics–2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119(3):480–6. https://doi.org/10.1161/circulationaha.108.191259.

Article  PubMed  Google Scholar 

Wilmot KA, et al. Coronary heart Disease Mortality declines in the United States from 1979 through 2011: evidence for stagnation in young adults, especially women. Circulation. 2015;132(11):997–1002. https://doi.org/10.1161/circulationaha.115.015293.

Article  PubMed  PubMed Central  Google Scholar 

Anagnostis P, et al. Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractions. Maturitas. 2015;81(1):62–8. https://doi.org/10.1016/j.maturitas.2015.02.262.

Article  CAS  PubMed  Google Scholar 

Roger VL, et al. Heart disease and stroke statistics–2011 update: a report from the American Heart Association. Circulation. 2011;123(4):e18–209. https://doi.org/10.1161/CIR.0b013e3182009701.

Article  PubMed  Google Scholar 

O’Hare EA, et al. Disruption of ldlr causes increased LDL-c and vascular lipid accumulation in a zebrafish model of hypercholesterolemia. J Lipid Res. 2014;55(11):2242–53. https://doi.org/10.1194/jlr.M046540.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Horton JD, Cohen JC, Hobbs HH. PCSK9: a convertase that coordinates LDL catabolism J Lipid Res, 2009;50 Suppl(Suppl):S172-7. https://doi.org/10.1194/jlr.R800091-JLR200.

Roelfsema F, Yang RJ, Veldhuis JD. Differential effects of Estradiol and Progesterone on Cardiovascular Risk factors in Postmenopausal Women. J Endocr Soc. 2018;2(7):794–805. https://doi.org/10.1210/js.2018-00073.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schnatz PF, et al. Effects of Calcium, Vitamin D, and hormone therapy on Cardiovascular Disease Risk factors in the women’s Health Initiative: a Randomized Controlled Trial. Obstet Gynecol. 2017;129(1):121–9. https://doi.org/10.1097/aog.0000000000001774.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jackson KG, et al. Olive oil increases the number of triacylglycerol-rich chylomicron particles compared with other oils: an effect retained when a second standard meal is fed. Am J Clin Nutr. 2002;76(5):942–9. https://doi.org/10.1093/ajcn/76.5.942.

Article  CAS  PubMed  Google Scholar 

Parini P, Angelin B, Rudling M. Importance of estrogen receptors in hepatic LDL receptor regulation. Arterioscler Thromb Vasc Biol. 1997;17(9):1800–5. https://doi.org/10.1161/01.atv.17.9.1800.

Article  CAS  PubMed  Google Scholar 

Ribas V, et al. Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice. Am J Physiol Endocrinol Metab. 2010;298(2). https://doi.org/10.1152/ajpendo.00504.2009. p. E304-19.

Geary N, et al. Deficits in E2-dependent control of feeding, weight gain, and cholecystokinin satiation in ER-alpha null mice. Endocrinology. 2001;142(11):4751–7. https://doi.org/10.1210/endo.142.11.8504.

Article  CAS  PubMed  Google Scholar 

Li C, et al. Requirement of Sp1 and estrogen receptor alpha interaction in 17beta-estradiol-mediated transcriptional activation of the low density lipoprotein receptor gene expression. Endocrinology. 2001;142(4):1546–53. https://doi.org/10.1210/endo.142.4.8096.

Article  CAS  PubMed  Google Scholar 

Villablanca AC et al. 17beta-estradiol prevents early-stage atherosclerosis in estrogen receptor-alpha deficient female mice J Cardiovasc Transl Res, 2009;2(3):289– 99. https://doi.org/10.1007/s12265-009-9103-z.

Wang Y, et al. Molecular characterization of proprotein convertase subtilisin/kexin type 9-mediated degradation of the LDLR. J Lipid Res. 2012;53(9):1932–43. https://doi.org/10.1194/jlr.M028563.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cui Q, et al. Serum PCSK9 is associated with multiple metabolic factors in a large Han Chinese population. Atherosclerosis. 2010;213(2):632–6. https://doi.org/10.1016/j.atherosclerosis.2010.09.027.

Article  CAS  PubMed  Google Scholar 

Fu W, et al. 17β-Estradiol inhibits PCSK9-Mediated LDLR degradation through GPER/PLC activation in HepG2 cells. Front Endocrinol (Lausanne). 2019;10:930. https://doi.org/10.3389/fendo.2019.00930.

Article  PubMed  Google Scholar 

Guo WJ, et al. Contribution of high-fat diet-induced PCSK9 upregulation to a mouse model of PCOS is mediated partly by SREBP2. Reproduction. 2021;162(6):397–410. https://doi.org/10.1530/rep-21-0164.

Article  CAS  PubMed  Google Scholar 

Lakoski SG, et al. Genetic and metabolic determinants of plasma PCSK9 levels. J Clin Endocrinol Metab. 2009;94(7):2537–43. https://doi.org/10.1210/jc.2009-0141.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ruscica M, et al. Circulating levels of Proprotein Convertase Subtilisin/Kexin Type 9 and arterial stiffness in a large Population Sample: Data from the Brisighella Heart Study. J Am Heart Assoc. 2017;6(5). https://doi.org/10.1161/jaha.117.005764.

Jeenduang N. Circulating PCSK9 concentrations are increased in postmenopausal women with the metabolic syndrome. Clin Chim Acta. 2019;494:151–6. https://doi.org/10.1016/j.cca.2019.04.067.

Article  CAS  PubMed  Google Scholar 

Cariou B, et al. PCSK9 dominant negative mutant results in increased LDL catabolic rate and familial hypobetalipoproteinemia. Arterioscler Thromb Vasc Biol. 2009;29(12):2191–7. https://doi.org/10.1161/atvbaha.109.194191.

Article  CAS  PubMed  Google Scholar 

Cohen JC, et al. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med. 2006;354(12):1264–72. https://doi.org/10.1056/NEJMoa054013.

Article  CAS  PubMed  Google Scholar 

Rashid S, et al. Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9. Proc Natl Acad Sci U S A. 2005;102(15):5374–9. https://doi.org/10.1073/pnas.0501652102.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ooi TC, et al. Relationship between testosterone, estradiol and circulating PCSK9: cross-sectional and interventional studies in humans. Clin Chim Acta. 2015;446:97–104. https://doi.org/10.1016/j.cca.2015.03.036.

Article  CAS  PubMed  Google Scholar 

Persson L, et al. Importance of proprotein convertase subtilisin/kexin type 9 in the hormonal and dietary regulation of rat liver low-density lipoprotein receptors. Endocrinology. 2009;150(3):1140–6. https://doi.org/10.1210/en.2008-1281.

Article  CAS  PubMed  Google Scholar 

Ghosh M, et al. Influence of physiological changes in endogenous estrogen on circulating PCSK9 and LDL cholesterol. J Lipid Res. 2015;56(2):463–9. https://doi.org/10.1194/jlr.M055780.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Starr AE, et al. β-Estradiol results in a proprotein convertase subtilisin/kexin type 9-dependent increase in low-density lipoprotein receptor levels in human hepatic HuH7 cells. Febs j. 2015;282(14):2682–96. https://doi.org/10.1111/febs.13309.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roubtsova A et al. PCSK9 deficiency results in a specific shedding of excess LDLR in female mice only: Role of hepatic cholesterol Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2022;1867(12). https://doi.org/10.1016/j.bbalip.2022.159217.

Maarouf N, et al. Unlike estrogens that increase PCSK9 levels post-menopause HSP27 vaccination lowers cholesterol levels and atherogenesis due to divergent effects on PCSK9 and LDLR. Pharmacol Res. 2020;161. https://doi.org/10.1016/j.phrs.2020.105222.